Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083350 | SCV000261781 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224052 | SCV000280731 | benign | not provided | 2015-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000437592 | SCV000529303 | benign | not specified | 2016-10-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Personalized Diabetes Medicine Program, |
RCV000445530 | SCV000536993 | benign | Monogenic diabetes | 2019-02-08 | criteria provided, single submitter | research | ACMG criteria: BP4 (REVEL 0.064 + 7 predictors; not using PP3/3 predictors), BA1 (6.3% MAF in gnomAD Africans), BS2 (56 homozygotes in gnomAD), BP1 (most ALMS1 pathogenic variants are truncating)=benign |
Laboratory for Molecular Medicine, |
RCV000437592 | SCV000711831 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Gly3755Ser in exon 16 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 6.45% (623/9664) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs34927702). |
Athena Diagnostics | RCV000224052 | SCV001142996 | benign | not provided | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV001083350 | SCV002605272 | benign | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs34927702 in Alstrom syndrome yet. | |
Ambry Genetics | RCV002433911 | SCV002753467 | benign | Cardiovascular phenotype | 2018-12-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000224052 | SCV005242484 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001083350 | SCV001455022 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000437592 | SCV002034078 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000224052 | SCV002036244 | likely benign | not provided | no assertion criteria provided | clinical testing |